Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1211 of 5804
-
Exercise eases PTSD and improves sleep in quake survivors, study finds
Symptom relief CompletedThis randomized controlled trial aims to examine the effects of a moderate-intensity aerobic exercise program on post-traumatic stress disorder (PTSD) symptoms and sleep quality among earthquake survivors living in temporary accommodation centers. Participants are randomly assign…
Phase: NA • Sponsor: Malatya Turgut Ozal University • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
New injection aims to tame kidney disease
Disease control Not yet recruitingThis study is divided into two parts (Part A and Part B). This study aims to evaluate the safety and efficacy of CM313 in subjects with primary Immunoglobulin A nephropathy(IgAN), while also observing its Pharmacokinetics(PK) characteristics, Pharmacokinetics(PD) effects, and imm…
Phase: PHASE2 • Sponsor: Keymed Biosciences Co.Ltd • Aim: Disease control
Last updated Jun 26, 2026 18:51 UTC
-
Electric pulses to the lungs: a new hope for COPD cough?
Symptom relief Recruiting nowThis is a prospective, randomized, parallel group, sham-controlled, multicenter clinical trial. The objective is to evaluate the safety and effectiveness of pulsed electric field ablation system manufactured by Suzhou Hengruihongyuan Medical Technology Co., Ltd. for the treatment…
Phase: NA • Sponsor: Suzhou Hengruihongyuan Medical Technology Co. LTD • Aim: Symptom relief
Last updated Jun 26, 2026 12:32 UTC
-
Tiny needle, big hope: new eye surgery trial for sudden blindness
Disease control Recruiting nowThis prospective interventional study evaluates the efficacy and safety of direct intra-arterial microneedle injection combined with pars plana vitrectomy for acute retinal artery occlusion (including central retinal artery occlusion \[CRAO\] and branch retinal artery occlusion \…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 26, 2026 12:38 UTC
-
Can cashew allergy be outgrown? new study tests oral immunotherapy
Disease control Not yet recruitingThis study is a long-term follow-up of participants from the randomized controlled trial (RCT) "Efficacy of Cashew Nut Protein Immunotherapy: A Protocol of a Single-Center Randomized Controlled Trial in the Pediatric Population", NCT06328504. At the end of the original RCT all pa…
Phase: NA • Sponsor: Medical University of Warsaw • Aim: Disease control
Last updated Jun 26, 2026 14:38 UTC
-
New study aims to catch heart risks early in cancer treatment
Knowledge-focused Recruiting nowThis study will prospectively monitor cancer patients receiving chemotherapy (including molecular targeted therapies) for cardiovascular adverse events using biomarkers and imaging. The goal is to develop a predictive model for major adverse cardiovascular events (MACE) in this p…
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Could a vitamin B12 shot help kids with MMA? new trial underway
Disease control Not yet recruitingThis study is a Single-Center, Single-Arm, open-label, Phase III clinical study to evaluate the efficacy, safety characteristics of Hydroxocobalamin Chloride Injection (20 mg/mL) for Maintenance Therapy in participants with Methylmalonic Acidemia (MMA) with Elevated Homocysteine …
Phase: PHASE3 • Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 14:49 UTC
-
New blood thinner may beat aspirin for aneurysm patients
Disease control Recruiting nowThis project aims to evaluate the safety and efficacy of the antiplatelet regimen combining indobufen and clopidogrel in preventing ischemic events after stent-assisted coiling embolization and flow diverter implantation for intracranial aneurysms. Using a randomization system, …
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New ultrasound technique could spot deadly varices without a scope
Diagnosis Recruiting nowTo evaluate the diagnostic value of the combined model of subharmonic-assisted pressure estimation (SHAPE), liver stiffness (LSM), and platelet count (PLT) for high-risk esophageal and gastric varices (HRV)
Phase: NA • Sponsor: The First Hospital of Jilin University • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
Could common antioxidants help thalassemia patients?
Disease control Not yet recruitingThe current study is to investigate the potential roles of N-acetyl cysteine and Alpha-lipoic acid in patients with beta-thalassemia.
Phase: PHASE3 • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 26, 2026 14:23 UTC
-
Could a probiotic protect pregnant women and their babies from gut damage?
Disease control Recruiting nowBurden: Environmental Enteric Dysfunction (EED) is an enteropathic condition characterised by altered gut permeability, infiltration of immune cells, and changes in villous architecture and cell differentiation. EED is a major reason of malnourishment, poor neurological developme…
Phase: PHASE2 • Sponsor: Aga Khan University • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Could a single drug infusion limit permanent heart damage during a heart attack?
Disease control CompletedThis Phase Ila trial evaluates whether the intravenous administration of Dexrazoxane can reduce permanent heart muscle damage in patients undergoing standard stent procedures (PCI) for a severe heart attack (STEMI).
Phase: PHASE2 • Sponsor: Rohan Dharmakumar • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Socks against side effects: simple stockings may shield nerves during chemo
Prevention Recruiting nowThis multicenter, prospective phase II clinical trial aims to evaluate the efficacy and safety of medical compression stockings in preventing peripheral neuropathy induced by antibody-drug conjugates (ADCs) containing monomethyl auristatin E (MMAE) in patients with advanced cance…
Phase: NA • Sponsor: Sheng Zhang • Aim: Prevention
Last updated Jun 26, 2026 16:56 UTC
-
Bladder cancer breakthrough? MRI may predict chemo success in days
Diagnosis Recruiting nowBladder cancer is a prevalent malignancy globally, with muscle-invasive disease having a five-year survival rate below 50%. Neoadjuvant chemotherapy (NAC) before radical cystectomy has shown efficacy for resectable muscle-invasive bladder cancer (MIBC). However, non-response to N…
Sponsor: Assiut University • Aim: Diagnosis
Last updated Jun 27, 2026 07:52 UTC
-
Could a simple amino acid ease GRIN disorder symptoms? new trial aims to find out.
Disease control Recruiting nowThe goal of this clinical study is to find out whether L-serine dietary supplementation helps improve overall clinical functioning in children and young adults (2-30 years) with GRIN-related neurodevelopmental disorders (GRIN-NDD) caused by loss-of-function (LoF) variants in GRIN…
Phase: PHASE3 • Sponsor: Meyer Children's Hospital IRCCS • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Supercharged immune cells take on advanced cancers
Disease control Recruiting nowA Study of Metabolically Armed Tumor-Infiltrating Lymphocytes (Meta10-TIL) Therapy for Patients With Advanced Solid Tumors
Phase: EARLY_PHASE1 • Sponsor: Anhui Provincial Hospital • Aim: Disease control
Last updated Jun 26, 2026 16:55 UTC
-
Gene therapy for rare heart disease passes early safety check
Disease control ENROLLING_BY_INVITATIONThe primary objective of this Phase 1/2 long-term follow-up (LTFU) study is to assess the long-term safety and tolerability of LX2020 for the treatment of arrhythmogenic cardiomyopathy (ACM) due to a plakophilin-2 gene (PKP2) pathogenic variant (PKP2-ACM).
Sponsor: Lexeo Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Quick chagas tests could speed up diagnosis in argentina
Diagnosis Recruiting nowChagas disease (CD) is the most significant endemic zoonosis in Argentina. Two-thirds of affected individuals live in urban areas but only 10% globally are aware of their infection. Diagnosing Chronic Chagas (CCD) requires at least two serological tests, often limited to referenc…
Sponsor: Instituto Nacional de Parasitologia Dr. Mario Fatala Chaben • Aim: Diagnosis
Last updated Jun 27, 2026 08:12 UTC
-
Second dose of experimental drug may help heart amyloidosis patients
Disease control OngoingThis is a Phase 2, single-arm, multicenter study to evaluate the pharmacodynamics and safety of re-treatment with ALXN2220 in previous participants of Study NI006-101.
Phase: PHASE2 • Sponsor: Neurimmune AG • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New siRNA drug aims to tame kidney disease
Disease control Recruiting nowThis Phase 2 study is designed to assess the safety, efficacy, pharmacokinetics (PK) and pharmacodynamics (PD) of ADX-038 in adults with complement-mediated kidney diseases.
Phase: PHASE2 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC